Z.A.A. Wainberg

机构：University of California, Los Angeles

发表论文 6 篇 · 总被引 19 次 · h-index 3

代表论文

916O Preliminary phase I results of INCB161734, a novel oral KRAS G12D inhibitor, in patients with advanced or metastatic solid tumors (2025 · Annals of Oncology · 被引 10)
LBA10 Bemarituzumab (BEMA) plus chemotherapy for advanced or metastatic FGFR2b-overexpressing gastric or gastroesophageal junction cancer (G/GEJC): FORTITUDE-101 phase III study results (2025 · Annals of Oncology · 被引 5)
919O A first-in-human study of oral IAG933 in adult patients with advanced mesothelioma and other solid tumours (2025 · Annals of Oncology · 被引 3)
195TiP A first-in-human, phase I a/b dose escalation and expansion study to evaluate RBS2418 as monotherapy and in combination with pembrolizumab in subjects with advanced unresectable, recurrent or metastatic tumors (2022 · Immuno-Oncology Technology · 被引 1)
Corrigendum to “925MO First-in-human phase I/Ib study of the oral Werner (WRN) helicase inhibitor HRO761 in patients (pts) with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) advanced solid tumors: Interim safety and efficacy analysis from HRO761 single agent dose escalation” (2026 · Annals of Oncology)
LBA34 DeFianCe trial: A randomized phase II trial of sirexatamab (DKN-01) plus bevacizumab and chemotherapy versus bevacizumab and chemotherapy as second-line therapy in advanced microsatellite stable (MSS) colorectal cancer (CRC) (2025 · Annals of Oncology)